Nicorandil but not ISDN Upregulates Endothelial Nitric Oxide Synthase Expression, Preventing Left Ventricular Remodeling and Degradation of Cardiac Function in Dahl Salt-sensitive Hypertensive Rats With Congestive Heart Failure

Cardiac endothelial nitric oxide synthase (ecNOS) was suppressed and inducible NOS (iNOS) enhanced at the decompensated heart failure stage in 18-week-old Dahl salt-sensitive (DS) hypertensive rats to which a high-salt diet had been administered from the age of 6 weeks. Nicorandil (NIC) enhanced ecNOS by activating Adenosine triphosphate-sensitive potassium channels (K-ATP channels) in the normal rat left ventricle. In this study, left ventricular hypertrophy, remodeling, function, cardiac ecNOS, and iNOS were compared between NIC and isosorbide dinitrate (ISDN) treatments in DS hypertensive rats with congestive heart failure. We examined DS hypertensive rats of 18 weeks of age to which 8% NaCl had been administered from the age of 6 weeks, and to which subdepressor doses of NIC (6 mg/kg/d), ISDN (6 mg/kg/d), and vehicle (CON) were administered from the age of 11 weeks. Contractility (Ees), stiffness (Eed), left ventricular end-diastolic volume, and left ventricular end-systolic volume were measured by conductance catheter and micromanometer on the basis of the pressure-volume relationship, and mRNA and protein levels of ecNOS and iNOS in the left ventricle were measured by reverse transcription-polymerase chain reaction and Western blot analysis at 18 weeks. LV mass index and LV dimensions were smaller in the NIC and ISDN groups than in the CON group (P<0.01), and the first parameter was lower in the NIC than in the ISDN group (P<0.01). Ees was also better maintained in the NIC and ISDN groups than in the CON group (NIC: 3349±649; ISDN: 2950±577, P<0.05 vs. NIC; CON: 1424±375 mL/mmHg, P<0.01 vs. treatments). Eed was exacerbated only in the ISDN group. NIC enhanced whereas ISDN suppressed ecNOS mRNA and protein levels (NIC 2.0-fold and 1.8-fold, ISDN 0.70-fold and 0.8-fold vs. CON; P<0.01, respectively). However, no intragroup differences in iNOS mRNA or protein levels were observed for the 3 groups. More significant improvements in cardiac function and LV hypertrophy regression were observed in an NIC group than in an ISDN group of DS hypertensive rats. Activation of the K-ATP channel seems to induce this beneficial effect, which may be mediated in part by enhanced ecNOS expression in the heart in DS hypertensive congestive heart failure rat model.

[1]  T. Naoe,et al.  Nicorandil Promotes Myocardial Capillary and Arteriolar Growth in the Failing Heart of Dahl Salt-Sensitive Hypertensive Rats , 2005, Hypertension.

[2]  C. Higgins,et al.  Long-Term Oral Treatment with Nicorandil Prevents the Progression of Left Ventricular Hypertrophy and Preserves Viability , 2005, Journal of cardiovascular pharmacology.

[3]  E. Jaimes,et al.  Atorvastatin Prevents End-Organ Injury in Salt-Sensitive Hypertension: Role of eNOS and Oxidant Stress , 2004, Hypertension.

[4]  A. Yamada,et al.  Nicorandil inhibits oxidative stress-induced apoptosis in cardiac myocytes through activation of mitochondrial ATP-sensitive potassium channels and a nitrate-like effect. , 2003, Journal of molecular and cellular cardiology.

[5]  H. Yagi,et al.  Expression of inducible nitric oxide synthase, left ventricular function and remodeling in Dahl salt-sensitive hypertensive rats. , 2003, International journal of cardiology.

[6]  G. Schmid-Schönbein,et al.  Nicorandil and Leukocyte Activation , 2002, Journal of cardiovascular pharmacology.

[7]  M. Hori,et al.  Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase. , 2002, Journal of the American College of Cardiology.

[8]  Maythem Saeed,et al.  Left ventricular remodeling after infarction: sequential MR imaging with oral nicorandil therapy in rat model. , 2002, Radiology.

[9]  K. Hirata,et al.  Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[10]  M. Oz,et al.  Endogenous endothelium-derived nitric oxide inhibits myocardial caspase activity: implications for treatment of end-stage heart failure. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  W. Hillis,et al.  Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial , 2002, The Lancet.

[12]  T. Marwick,et al.  Vascular dysfunction and heart failure: epiphenomenon or etiologic agent? , 2002, American heart journal.

[13]  M. Hamada,et al.  Relationship between cardiomyocyte cell death and cardiac function during hypertensive cardiac remodelling in Dahl rats , 2002 .

[14]  J. Balligand,et al.  Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes , 2001, Nature Cell Biology.

[15]  Richard T. Lee,et al.  Endothelial Nitric Oxide Synthase Limits Left Ventricular Remodeling After Myocardial Infarction in Mice , 2001, Circulation.

[16]  N. Kobayashi,et al.  Nicorandil Enhances Cardiac Endothelial Nitric Oxide Synthase Expression via Activation of Adenosine Triphosphate‐Sensitive K Channel in Rat , 2001, Journal of cardiovascular pharmacology.

[17]  G. Kojda,et al.  Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart , 2000, The Journal of physiology.

[18]  N. Kobayashi,et al.  Effects of imidapril on NOS expression and myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats. , 1999, Cardiovascular research.

[19]  X. Wang,et al.  cGMP-mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide. , 1999, Hypertension.

[20]  E. Lakatta,et al.  Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. , 1999, Circulation research.

[21]  R. Ritchie,et al.  Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide. , 1998, American journal of physiology. Heart and circulatory physiology.

[22]  M. Sugimachi,et al.  ESPVR of in situ rat left ventricle shows contractility-dependent curvilinearity. , 1998, American journal of physiology. Heart and circulatory physiology.

[23]  N. Takahashi,et al.  Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. , 1998, The Journal of clinical investigation.

[24]  J. Stamler,et al.  Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. , 1998, Science.

[25]  M. Arai,et al.  Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits. , 1997, International journal of cardiology.

[26]  Y. Hattori,et al.  Pyrrolidine dithiocarbamate inhibits cytokine-induced VCAM-1 gene expression in rat cardiac myocytes , 1997, Molecular and Cellular Biochemistry.

[27]  G. Gross,et al.  Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. , 1997, The American journal of physiology.

[28]  G. Grover Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion. , 1997, Canadian journal of physiology and pharmacology.

[29]  T. Yoshimoto,et al.  Gene expression of endothelial type isoform of nitric oxide synthase in various tissues of stroke-prone spontaneously hypertensive rats. , 1997, Hypertension research : official journal of the Japanese Society of Hypertension.

[30]  J. Stamler,et al.  Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols , 1996, The Journal of general physiology.

[31]  H. Suga,et al.  Left ventricular volumetric conductance catheter for rats. , 1996, The American journal of physiology.

[32]  A. Dolphin,et al.  Anti-Ig-induced Calcium Influx in Rat B Lymphocytes Mediated by cGMP through a Dihydropyridine-sensitive Channel (*) , 1996, The Journal of Biological Chemistry.

[33]  A. Galione,et al.  Nitric Oxide-induced Mobilization of Intracellular Calcium via the Cyclic ADP-ribose Signaling Pathway (*) , 1996, The Journal of Biological Chemistry.

[34]  K. Shirato,et al.  Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels. , 1995, Journal of cardiovascular pharmacology.

[35]  G. Gross,et al.  Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. , 1995, Cardiovascular research.

[36]  H. Suga Paul Dudley White International Lecture: cardiac performance as viewed through the pressure-volume window. , 1994, Japanese heart journal.

[37]  R Fischmeister,et al.  Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. , 1993, The Journal of biological chemistry.

[38]  Y. Hattori,et al.  GTP cyclohydrolase I mRNA is induced by LPS in vascular smooth muscle: characterization, sequence and relationship to nitric oxide synthase. , 1993, Biochemical and biophysical research communications.

[39]  N. Ishida,et al.  Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. , 1993, Biochemical and biophysical research communications.

[40]  F. Marumo,et al.  Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments. , 1992, The Journal of clinical investigation.

[41]  N. Taira,et al.  Nicorandil as a hybrid between nitrates and potassium channel activators. , 1989, The American journal of cardiology.

[42]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[43]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[44]  S. Holzmann Cyclic GMP as Possible Mediator of Coronary Arterial Relaxation by Nicorandil (SG‐75) , 1983, Journal of cardiovascular pharmacology.

[45]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[47]  A. Shoukas,et al.  Load Independence of the Instantaneous Pressure‐Volume Ratio of the Canine Left Ventricle and Effects of Epinephrine and Heart Rate on the Ratio , 1973, Circulation research.

[48]  Hiroyuki Suga,et al.  Mathematical interrelationship between instantaneous ventricular pressure-volume ratio and myocardial force-velocity relation , 1972, Annals of Biomedical Engineering.

[49]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[50]  H. Yagi,et al.  Nicorandil Protects Against Lethal Ischemic Ventricular Arrhythmias and Up-regulates Endothelial Nitric Oxide Synthase Expression and Sulfonylurea Receptor 2 mRNA in Conscious Rats with Acute Myocardial Infarction , 2004, Cardiovascular Drugs and Therapy.

[51]  Joao A. C. Lima,et al.  Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms , 2002, Nature.

[52]  M. Hamada,et al.  Relationship between cardiomyocyte cell death and cardiac function during hypertensive cardiac remodelling in Dahl rats. , 2002, Clinical science.

[53]  P. Vanhoutte,et al.  Endothelial dysfunction: from physiology to therapy. , 1999, Journal of molecular and cellular cardiology.

[54]  G. Kojda,et al.  Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. , 1996, Circulation research.

[55]  赤井 健次郎 Vasodilatory effect of nicorandil an coronary arterial microvessels. (微小冠動脈におけるニコランジルの血管拡張作用) , 1994 .

[56]  R. Applegate,et al.  Cardiac Contraction and the Pressure-Volume Relationship , 1990 .